Filter posts

Fewer Small Public Biotechs Today

A lot can happen in six years. The number of active biotech companies currently trading …

Emerging Company Policy Deconstructed: Fostering Innovation Act (H.R. 2629)

In a nutshell: Representative Michael Fitzpatrick (R-PA) introduced H.R. 2629, the Fostering Innovation Act, to …

The Value of Partnering Continues to be a Draw for BIO Events

Last month’s BIO Convention in China saw 700 partnering meetings between executives from biotechnology, pharmaceutical companies and investment …

Biotech Stocks Hit Record Highs...Again

Biotech stocks hit an all-time high this week, driven by strong performance among large cap …

NYC Launches $100M Life Science Fund

On Tuesday, Deputy Mayor Robert Steel announced that the city is launching the New York …

Emerging Company Policy Deconstructed: Small Cap Liquidity Reform Act (H.R. 3448)

In a nutshell: This bill, sponsored by Reps. Sean Duffy (R-WI) and John Carney (D-DE), …

Emerging Company Policy Deconstructed: Start-up Jobs and Innovation Act (S. 1658)

In a nutshell: Senators Robert Menendez (D-NJ) and Pat Toomey (R-PA) introduced the Start-up Jobs …

Innovation Is… with Doug Doerfler of MaxCyte

The term innovation is thrown around more often than Peyton Manning’s name during Fantasy Football …

Innovation Is… with David Pyott of Allergan, Inc

The term innovation is thrown around more often than Peyton Manning’s name during Fantasy Football …

Innovation Is… with Stephan Tanda, Managing Board Member, Royal DSM

The term “innovation” is thrown around more often than Peyton Manning’s name during Fantasy Football …